Literature DB >> 14992433

The relationship between the esophageal tissue content of neurotensin and the presence or absence of esophageal inflammation.

Roy Dekel1, Robert E Carraway, Colleen Green, Ronnie Fass.   

Abstract

Neurotensin (NT) decreases lower esophageal sphincter pressure and impedes gastric emptying, thus exacerbating gastroesophageal reflux. The aim was to determine the content of esophageal tissue NT in patients with erosive esophagitis compared to those with normal endoscopy with or without abnormal acid exposure. Consecutive patients (N = 21) with gastroesophageal reflux disease symptoms underwent an upper endoscopy, at which two biopsies from opposite walls were obtained from normal-appearing mucosa. Patients with normal upper endoscopy underwent a pH test. NT tissue content was determined using radioimmunoassay. Six patients had erosive esophagitis, seven normal endoscopy but abnormal acid exposure, and eight both normal upper endoscopy and normal acid exposure. The NT/protein ratio was significantly higher in patients with normal upper endoscopy and normal or abnormal pH test compared to those with erosive esophagitis (8.7 +/- 1.4 and 8.0 +/- 1.2 vs. 3.8 +/- 0.5, respectively; P < 0.01). There was no significant difference in NT/protein ratio in patients with normal upper endoscopy with versus those without abnormal acid exposure (P = 0.7). There was no correlation between the extent of acid exposure and the NT/protein ratio. We suggest that the lower tissue content detected in patients with erosive esophagitis may represent a local protective mechanism against gastroesophageal reflux.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14992433     DOI: 10.1023/b:ddas.0000011600.60709.a1

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  27 in total

1.  Does delayed gastric emptying contribute to gastroesophageal reflux disease?

Authors:  W Schwizer; R A Hinder; T R DeMeester
Journal:  Am J Surg       Date:  1989-01       Impact factor: 2.565

2.  Enhancement of phagocytosis by neurotensin, a newly found biological activity of the neuropeptide.

Authors:  R Goldman; Z Bar-Shavit; E Shezen; S Terry; S Blumberg
Journal:  Adv Exp Med Biol       Date:  1982       Impact factor: 2.622

3.  Healing and relapse of severe peptic esophagitis after treatment with omeprazole.

Authors:  D J Hetzel; J Dent; W D Reed; F M Narielvala; M Mackinnon; J H McCarthy; B Mitchell; B R Beveridge; B H Laurence; G G Gibson
Journal:  Gastroenterology       Date:  1988-10       Impact factor: 22.682

4.  Neurotensin is a proinflammatory neuropeptide in colonic inflammation.

Authors:  I Castagliuolo; C C Wang; L Valenick; A Pasha; S Nikulasson; R E Carraway; C Pothoulakis
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

5.  Diagnostic value of histology in non-erosive gastro-oesophageal reflux disease.

Authors:  N E Schindlbeck; B Wiebecke; A G Klauser; W A Voderholzer; S A Müller-Lissner
Journal:  Gut       Date:  1996-08       Impact factor: 23.059

6.  Intestinal control of gastric tone.

Authors:  F Azpiroz; J R Malagelada
Journal:  Am J Physiol       Date:  1985-10

7.  Immunohistochemical localization of neurotensin in endocrine cells of the gut.

Authors:  F Sundler; R Håkanson; R A Hammer; J Alumets; R Carraway; S E Leeman; E A Zimmerman
Journal:  Cell Tissue Res       Date:  1977-03-16       Impact factor: 5.249

8.  The effect of ingestion of amino acids, glucose and fat on circulating neurotensin-like immunoreactivity (NTLI) in man.

Authors:  S Rosell; A Rökaeus
Journal:  Acta Physiol Scand       Date:  1979-11

9.  Characterization of radioimmunoassayable neurotensin in the rat. Its differential distribution in the central nervous system, small intestine, and stomach.

Authors:  R Carraway; S E Leeman
Journal:  J Biol Chem       Date:  1976-11-25       Impact factor: 5.157

10.  Stimulation of phagocytic function in mouse macrophages by neurotensin and neuromedin N.

Authors:  M De la Fuente; J J Garrido; R M Arahuetes; A Hernanz
Journal:  J Neuroimmunol       Date:  1993-01       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.